Logo image of BILI

BILIBILI INC-SPONSORED ADR (BILI) Stock Fundamental Analysis

NASDAQ:BILI - Nasdaq - US0900401060 - ADR

17.47  +0.49 (+2.89%)

After market: 17.5 +0.03 (+0.17%)

Fundamental Rating

2

Overall BILI gets a fundamental rating of 2 out of 10. We evaluated BILI against 72 industry peers in the Interactive Media & Services industry. Both the profitability and financial health of BILI have multiple concerns. BILI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BILI has reported negative net income.
BILI had negative earnings in each of the past 5 years.
In multiple years BILI reported negative operating cash flow during the last 5 years.
BILI Yearly Net Income VS EBIT VS OCF VS FCFBILI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2B -4B -6B

1.2 Ratios

With a Return On Assets value of -12.79%, BILI perfoms like the industry average, outperforming 43.28% of the companies in the same industry.
With a Return On Equity value of -29.48%, BILI perfoms like the industry average, outperforming 44.78% of the companies in the same industry.
Industry RankSector Rank
ROA -12.79%
ROE -29.48%
ROIC N/A
ROA(3y)-15.17%
ROA(5y)-13.29%
ROE(3y)-38%
ROE(5y)-34.38%
ROIC(3y)N/A
ROIC(5y)N/A
BILI Yearly ROA, ROE, ROICBILI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

BILI's Gross Margin of 27.35% is on the low side compared to the rest of the industry. BILI is outperformed by 82.09% of its industry peers.
In the last couple of years the Gross Margin of BILI has grown nicely.
BILI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y3.13%
BILI Yearly Profit, Operating, Gross MarginsBILI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

2

2. Health

2.1 Basic Checks

BILI does not have a ROIC to compare to the WACC, probably because it is not profitable.
BILI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BILI has more shares outstanding
BILI has a better debt/assets ratio than last year.
BILI Yearly Shares OutstandingBILI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
BILI Yearly Total Debt VS Total AssetsBILI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B 50B

2.2 Solvency

BILI has an Altman-Z score of 0.94. This is a bad value and indicates that BILI is not financially healthy and even has some risk of bankruptcy.
BILI has a Altman-Z score (0.94) which is in line with its industry peers.
BILI has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
BILI's Debt to Equity ratio of 0.36 is on the low side compared to the rest of the industry. BILI is outperformed by 61.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 0.94
ROIC/WACCN/A
WACC6.41%
BILI Yearly LT Debt VS Equity VS FCFBILI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B 10B 15B 20B

2.3 Liquidity

BILI has a Current Ratio of 1.02. This is a normal value and indicates that BILI is financially healthy and should not expect problems in meeting its short term obligations.
BILI has a worse Current ratio (1.02) than 74.63% of its industry peers.
A Quick Ratio of 1.02 indicates that BILI should not have too much problems paying its short term obligations.
The Quick ratio of BILI (1.02) is worse than 74.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
BILI Yearly Current Assets VS Current LiabilitesBILI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 75.90% over the past year.
BILI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.00%.
Measured over the past years, BILI shows a very strong growth in Revenue. The Revenue has been growing by 40.40% on average per year.
EPS 1Y (TTM)75.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.89%
Revenue 1Y (TTM)14%
Revenue growth 3Y23.37%
Revenue growth 5Y40.4%
Sales Q2Q%25.85%

3.2 Future

Based on estimates for the next years, BILI will show a very strong growth in Earnings Per Share. The EPS will grow by 29.78% on average per year.
Based on estimates for the next years, BILI will show a quite strong growth in Revenue. The Revenue will grow by 12.62% on average per year.
EPS Next Y97.71%
EPS Next 2Y60.67%
EPS Next 3Y42.59%
EPS Next 5Y29.78%
Revenue Next Year18.84%
Revenue Next 2Y16.07%
Revenue Next 3Y14.05%
Revenue Next 5Y12.62%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BILI Yearly Revenue VS EstimatesBILI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B
BILI Yearly EPS VS EstimatesBILI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 10 -10 20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

BILI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 26.53, which means the current valuation is very expensive for BILI.
BILI's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.11, BILI is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 26.53
BILI Price Earnings VS Forward Price EarningsBILI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BILI Per share dataBILI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

BILI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BILI's earnings are expected to grow with 42.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.67%
EPS Next 3Y42.59%

More info and screens

0

5. Dividend

5.1 Amount

BILI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BILIBILI INC-SPONSORED ADR

NASDAQ:BILI (1/17/2025, 8:00:00 PM)

After market: 17.5 +0.03 (+0.17%)

17.47

+0.49 (+2.89%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners21.74%
Inst Owner Change-0.11%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap7.26B
Analysts81.4
Price Target23.46 (34.29%)
Short Float %5.99%
Short Ratio3.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.82%
Min EPS beat(2)13.23%
Max EPS beat(2)14.41%
EPS beat(4)3
Avg EPS beat(4)8.27%
Min EPS beat(4)-12.16%
Max EPS beat(4)17.59%
EPS beat(8)7
Avg EPS beat(8)9%
EPS beat(12)10
Avg EPS beat(12)5.85%
EPS beat(16)13
Avg EPS beat(16)7.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-1.52%
Revenue beat(4)0
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)-1.43%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)0
Avg Revenue beat(12)-1.78%
Revenue beat(16)4
Avg Revenue beat(16)-0.6%
PT rev (1m)3.34%
PT rev (3m)28.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.16%
EPS NY rev (1m)0%
EPS NY rev (3m)59.64%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.53
P/S 2.22
P/FCF N/A
P/OCF N/A
P/B 3.92
P/tB 7.16
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)0.66
Fwd EY3.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.86
BVpS4.46
TBVpS2.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.79%
ROE -29.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.35%
FCFM N/A
ROA(3y)-15.17%
ROA(5y)-13.29%
ROE(3y)-38%
ROE(5y)-34.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y3.13%
F-ScoreN/A
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 0.94
F-ScoreN/A
WACC6.41%
ROIC/WACCN/A
Cap/Depr(3y)93.93%
Cap/Depr(5y)110.89%
Cap/Sales(3y)12.48%
Cap/Sales(5y)15.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.89%
EPS Next Y97.71%
EPS Next 2Y60.67%
EPS Next 3Y42.59%
EPS Next 5Y29.78%
Revenue 1Y (TTM)14%
Revenue growth 3Y23.37%
Revenue growth 5Y40.4%
Sales Q2Q%25.85%
Revenue Next Year18.84%
Revenue Next 2Y16.07%
Revenue Next 3Y14.05%
Revenue Next 5Y12.62%
EBIT growth 1Y44.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.7%
EBIT Next 3Y45.18%
EBIT Next 5Y28.4%
FCF growth 1Y84.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.82%
OCF growth 3Y-29.26%
OCF growth 5Y-18.41%